Ricola Group AG

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40014696

Informations générales

Localisation

Switzerland

Europe

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

08/08/2024

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2030

Statut

Targets set

Classification

1.5°C

Année cible

2030

Progression vers l'objectif73%
2015 (année de référence)2030
Description complète des objectifs

Ricola Group AG commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2022 base year.* Ricola Group AG also commits to reduce scope 3 GHG emissions 51.6% per CHF value added by 2030 within the same timeframe.*The target boundary includes land-related emissions and removals from bioenergy feedstocks.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Source : Science Based Targets initiative | Données publiques